Lingli Li

Lingli Li

Auto-generated profile, based on publicly available information

Lingli Li

Department of Pharmacy, Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui, 230001,China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Hypertension
Verified
Journal Article
Open access
LLLingli Li
Lingli Li
ELEn Yin Lai
En Yin Lai
ZLZaiming Luo
Zaiming Luo
GSGlenn Solis
Glenn Solis
MMMargarida Mendonca
Margarida Mendonca
CWChristopher S Wilcox
Christopher S Wilcox
High salt, Ang II (angiotensin II), and reactive oxygen species enhance progression of chronic kidney disease. We tested the hypothesis that a high salt intake generates specific reactive oxygen species to enhance Ang II contractions of afferent arterioles from mice with reduced renal mass (RRM). C57BL/6 mice were subjected to surgical RRM or sham operations and received 6% or 0.4% NaCl salt diet for 3 months. Ang II contractions were measured in perfused afferent arterioles and superoxide (O 2 − ) and hydrogen peroxide (H 2 O 2 ) by fluorescence microscopy. RRM enhanced the afferent arteriolar gene expression for p47 phox and neutrophil oxidase (NOX) 2 and high salt intake in RRM mice enhanced gene expression for angiotensin type 1 receptors, POLDIP2 and NOX4 and reduced catalase. High salt in mice with RRM enhanced arteriolar O 2 − and H 2 O 2 generation and maximal contractions to Ang II (10 –6 mol/L) that were dependent on O 2 − because they were prevented by gene deletion of p47 phox and on H 2 O 2 because they were prevented by transgenic smooth muscle cell expression of catalase (tg CAT-SMC ) and POLDIP2 gene deletion. Three months of tempol normalized arteriolar reactive oxygen species and Ang II contractions. However, arteriolar contractions to lower concentrations of Ang II (10 –8 to 10 –11 mol/L) were paradoxically inhibited by H 2 O 2 and POLDIP2. In conclusion, both O 2 − from p47 phox /NOX2 and H 2 O 2 from NOX4/POLDIP2 enhance maximal arteriolar Ang II contractions from RRM mice during high salt, but H 2 O 2 and NOX4/POLDIP2 reduce the sensitivity to lower concentrations of Ang II by >100-fold. Tempol prevents all of these changes in function.

1 September 2017 in Kidney International
Verified
Journal Article
Closed access
LLLingli Li
Lingli Li
ELEn Yin Lai
En Yin Lai
ZLZaiming Luo
Zaiming Luo
GSGlenn Solis
Glenn Solis
KGKathy K. Griendling
Kathy K. Griendling
CWChristopher S Wilcox
Christopher S Wilcox

1 December 2021 in Current Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
SZShengyu Zhang
Shengyu Zhang
LLLingli Li
Lingli Li
MDMingying Deng
Mingying Deng
YWYanan Wang
Yanan Wang
ASAiZong Shen
AiZong Shen
Lei ZhangLei Zhang
Lei Zhang
Background: Cardiovascular disease is the leading cause of death in both developed and developing countries. Di'ao Xinxuekang (DAXXK) is a pure Chinese medicine herbal preparation refined from dioscin extracted from the roots of Dioscorea panthaica Prain et Burk and Diosorea nipponica Makino. Objective: To evaluate the application of DAXXK in Cardiovascular disease. Methods: : We searched and summarized all the studies on DAXXK and Cardiovascular disease in pumend, Google, and CNKI. Results: Modern pharmacological studies have shown that DAXXK has pharmacological effects such as dilating blood vessels, lowering blood pressure and cardiac load, improving hemodynamics, lowering blood lipids and anti-platelet aggregation, and is widely used for the therapy of various kinds of cardiovascular diseases, including hypertension, atherosclerosis, coronary heart disease (CHD), angina pectoris (AP) and myocardial infarction. We provide an overview of the clinical efficacy, molecular mechanisms, safety and therapeutic potential of DAXXK in the treatment of cardiovascular disease, aiming to provide clues and evidence for clinical decision-making. Conclusion: DAXXK exerts cardiovascular protection by regulating a variety of cardiovascular disease-related signaling pathways.

1 March 2021 in Acta Oceanologica Sinica
Verified
Journal Article
Closed access
PDF file
WSWenyan Sui
Wenyan Sui
GRGuo jun Ru
Guo jun Ru
JSJun Song
Jun Song
ZLZhiliang Liu
Zhiliang Liu
MWMeng Wang
Meng Wang
WZWenting Zuo
Wenting Zuo